Categories AlphaGraphs, Earnings, Health Care
Key highlights from Eli Lilly’s (LLY) Q2 2025 earnings results
Eli Lilly and Company (NYSE: LLY) reported its second quarter 2025 earnings results today.
Worldwide revenue was $15.56 billion, up 38% from the same period a year ago.
GAAP net income increased 91% to $5.6 billion, or $6.29 per share, compared to last year. Adjusted EPS rose 61% to $6.31.
The company raised its full-year 2025 guidance based on strong business performance. Revenue is now expected to be $60-62 billion. GAAP EPS is now expected to be $20.85-22.10 while adjusted EPS is expected to be $21.75-23.00.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
